Biomune Systems, Inc. Stock Option Grant and Agreement Pursuant to the terms and conditions of the Biomune Systems, Inc. 1999 Stock Option and Incentive Plan (the "Plan"), Biomune Systems, Inc. (the "Company"), hereby grants to the Participant an...Biomune Systems Inc • February 2nd, 2000 • In vitro & in vivo diagnostic substances
Addendum AStock Option Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Washington
ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT ("Agreement") is made and entered into as of January __, 2000 (the "Effective Date") by and between Amerifit Nutrition, Inc. ("Seller"), a Delaware corporation with its principal place of business...Asset Purchase Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
LICENSE AGREEMENT This License Agreement (this "Agreement") is made effective as of January 13, 2000 (the "Effective Date") by and between Amerifit Nutrition, Inc., a Delaware corporation with its principal place of business at 166 Highland Park...License Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
1 EXHIBIT 10 CAPITAL CONTRIBUTION, ASSIGNMENT AND ASSUMPTION AGREEMENT KNOW ALL MEN BY THESE PRESENTS, that Donlar Corporation ("Donlar") for good and valuable consideration, the receipt of which is hereby acknowledged, and intending to be legally...Assignment and Assumption Agreement • January 22nd, 2001 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.95 LEASE AGREEMENTLease Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
Biomune Systems, Inc. Incentive Stock Option Grant and Agreement Pursuant to the terms and conditions of Biomune Systems, Inc. 1999 Stock Option and Incentive Plan (the "Plan"), Biomune Systems, Inc. (the "Company"), hereby grants to the Participant...Biomune Systems Inc • February 2nd, 2000 • In vitro & in vivo diagnostic substances
CONSULTING AGREEMENT THIS CONSULTING AGREEMENT ("Agreement") is entered into as of August 7, 2000 (the "Effective Date"), by and between Michael G. Acton, a resident of the State of Utah (the "Consultant") and Donlar Corporation, an Illinois...Consulting Agreement • August 15th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Illinois
RECITALS:License Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
WITNESSETH:Non-Competition Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
PURCHASE AGREEMENT PURCHASE AGREEMENT, dated as of May 27, 1998 (the "Agreement"), by and between CYPRESS SPRINGS LLC, a California limited liability company ("Cypress") managed by Ira E. Ritter, an individual residing in California ("Ritter"), and...Purchase Agreement • June 29th, 1998 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • California
EXTENSION AGREEMENTExtension Agreement • June 13th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
AGREEMENTAgreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
ARTICLE 1Asset Purchase Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 15th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Nevada
Exhibit 10.2 LETTER OF AGREEMENT This is a Letter of Agreement between Biomune Systems, Inc. (the "Company") and Joy M. Erickson ("Consultant") effective as of June 2, 1997. CONSULTING DUTIES Consultant has performed services for the Company which...Letter of Agreement • June 13th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
RECITALS:Stock Purchase Warrant • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.98 BIOMUNE SYSTEMS, INC. INVESTOR QUESTIONNAIRE AND SUBSCRIPTION AGREEMENT ALL SUBSCRIBERS FOR SHARES MUST EXECUTE AN INVESTOR QUESTIONNAIRE AND SUBSCRIPTION AGREEMENT. THIS INFORMATION IS NECESSARY FOR THE PURPOSE OF DETERMINING THE...Biomune Systems Inc • November 19th, 1996 • In vitro & in vivo diagnostic substances • Utah
AGREEMENTAgreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
AGREEMENTAgreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • California
AGREEMENTAgreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 15th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Nevada
AGREEMENTAgreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
Any party may change its address for notice hereunder by notice to the other parties hereto.Agreement • March 4th, 1998 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
among DONLAR CORPORATION and DONLAR BIOSYNTREX CORPORATIONBridge and Consolidated Term Loan Agreement • April 16th, 2002 • Donlar Biosyntrex Corp • In vitro & in vivo diagnostic substances • New York
Exhibit 10.135 EMPLOYMENT AGREEMENT This Employment Agreement is made this 1st day of July, 1996, by and between DONLAR CORPORATION, an Illinois corporation (the "Company"), having a principal place of business at Moffett Campus, 6502 South Archer...Employment Agreement • April 17th, 2002 • Donlar Biosyntrex Corp • In vitro & in vivo diagnostic substances • Illinois
EXHIBIT 10.117 MARKETING AND CONSULTING SERVICES AGREEMENT THIS MARKETING AND CONSULTING AGREEMENT (the "Agreement") is made as of August 14, 1999, effective April 1, 1999, by and between Harrogate Marketing, L.L.C. ("Harrogate") and Biomune Systems,...Marketing and Consulting Services Agreement • January 13th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
WITNESSETH:Biomune Systems Inc • November 19th, 1996 • In vitro & in vivo diagnostic substances • Utah
Product License and Distribution Agreement This PRODUCT LICENSE AND DISTRIBUTION AGREEMENT (the "Agreement") is made as of September 25, 1998 (the "Effective Date") by and between Medical Foods, Inc., a Delaware corporation, having principal place of...License and Distribution Agreement • January 13th, 1999 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Massachusetts
WITNESSETH:Biomune Systems Inc • November 19th, 1996 • In vitro & in vivo diagnostic substances • Utah
Employment Agreement ROBERT P. PIETRANGELO SEPTEMBER 7, 2001Employment Agreement • April 17th, 2002 • Donlar Biosyntrex Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.5 Biomune Systems, Inc. INCENTIVE STOCK OPTION AGREEMENT Biomune Systems, Inc., a Nevada corporation (the "Company"), hereby grants this 23rd day of October, 1996, to Frank Eldredge, an individual (the "Employee"), an option to purchase a...Incentive Stock Option Agreement • December 18th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 10.111 TERMINATION AND MUTUAL RELEASE AGREEMENT THIS TERMINATION AND MUTUAL RELEASE AGREEMENT (the "Agreement") is entered into effective as of this 1st day of September, 1996, by and between Biomune Systems, Inc., a Nevada corporation (the...Termination and Mutual Release Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
June 14, 2001Biomune Systems Inc • June 27th, 2001 • In vitro & in vivo diagnostic substances
June 13, 2001 Mr. Michael Acton 858 Green Oaks Drive Murray, UT 84123 Dear Mr. Acton: This letter sets forth the terms whereby Biomune Systems, Inc., a Nevada corporation ("Biomune"), agrees to retain Michael Acton to act as consultant and advisor to...Biomune Systems Inc • June 27th, 2001 • In vitro & in vivo diagnostic substances
